These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 29475078)

  • 41. Mild cognitive impairment in patients with Parkinson's disease is associated with increased cortical degeneration.
    Hanganu A; Bedetti C; Jubault T; Gagnon JF; Mejia-Constain B; Degroot C; Lafontaine AL; Chouinard S; Monchi O
    Mov Disord; 2013 Sep; 28(10):1360-9. PubMed ID: 23801590
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The influence of age and mild cognitive impairment on associative memory performance and underlying brain networks.
    Oedekoven CS; Jansen A; Keidel JL; Kircher T; Leube D
    Brain Imaging Behav; 2015 Dec; 9(4):776-89. PubMed ID: 25381653
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Large intracranial volume accelerates conversion to dementia in males and APOE4 non-carriers with mild cognitive impairment.
    An H; Son SJ; Cho S; Cho EY; Choi B; Kim SY;
    Int Psychogeriatr; 2016 May; 28(5):769-78. PubMed ID: 26674540
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Left Frontal Hub Connectivity during Memory Performance Supports Reserve in Aging and Mild Cognitive Impairment.
    Franzmeier N; Hartmann JC; Taylor ANW; Araque Caballero MÁ; Simon-Vermot L; Buerger K; Kambeitz-Ilankovic LM; Ertl-Wagner B; Mueller C; Catak C; Janowitz D; Stahl R; Dichgans M; Duering M; Ewers M
    J Alzheimers Dis; 2017; 59(4):1381-1392. PubMed ID: 28731448
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Visual Evaluation of Medial Temporal Lobe Atrophy as a Clinical Marker of Conversion from Mild Cognitive Impairment to Dementia and for Predicting Progression in Patients with Mild Cognitive Impairment and Mild Alzheimer's Disease.
    Persson K; Barca ML; Eldholm RS; Cavallin L; Šaltytė Benth J; Selbæk G; Brækhus A; Saltvedt I; Engedal K
    Dement Geriatr Cogn Disord; 2017; 44(1-2):12-24. PubMed ID: 28614836
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Cortical thickness contributes to cognitive heterogeneity in patients with type 2 diabetes mellitus.
    Li C; Li C; Yang Q; Wang B; Yin X; Zuo Z; Hu X; Lai Y; Wang J
    Medicine (Baltimore); 2018 May; 97(21):e10858. PubMed ID: 29794784
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Apolipoprotein E genotype is not associated with cognitive impairment in older adults with bipolar disorder.
    Kerr DS; Stella F; Radanovic M; Aprahamian I; Bertollucci PH; Forlenza OV
    Bipolar Disord; 2016 Feb; 18(1):71-7. PubMed ID: 26877211
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Association between Cerebrospinal Fluid Biomarkers for Alzheimer's Disease, APOE Genotypes and Auditory Verbal Learning Task in Subjective Cognitive Decline, Mild Cognitive Impairment, and Alzheimer's Disease.
    Mandecka M; Budziszewska M; Barczak A; Pepłońska B; Chodakowska-Żebrowska M; Filipek-Gliszczyńska A; Nesteruk M; Styczyńska M; Barcikowska M; Gabryelewicz T
    J Alzheimers Dis; 2016 Jul; 54(1):157-68. PubMed ID: 27472875
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Joint effects of gray matter atrophy and altered functional connectivity on cognitive deficits in amnestic mild cognitive impairment patients.
    Xie C; Bai F; Yuan B; Yu H; Shi Y; Yuan Y; Wu D; Zhang ZS; Zhang ZJ
    Psychol Med; 2015 Jul; 45(9):1799-810. PubMed ID: 25511078
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Diagnostic differentiation of mild cognitive impairment due to Alzheimer's disease using a hippocampus-dependent test of spatial memory.
    Moodley K; Minati L; Contarino V; Prioni S; Wood R; Cooper R; D'Incerti L; Tagliavini F; Chan D
    Hippocampus; 2015 Aug; 25(8):939-51. PubMed ID: 25605659
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Cerebral quantitative susceptibility mapping predicts amyloid-β-related cognitive decline.
    Ayton S; Fazlollahi A; Bourgeat P; Raniga P; Ng A; Lim YY; Diouf I; Farquharson S; Fripp J; Ames D; Doecke J; Desmond P; Ordidge R; Masters CL; Rowe CC; Maruff P; Villemagne VL; ; Salvado O; Bush AI
    Brain; 2017 Aug; 140(8):2112-2119. PubMed ID: 28899019
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Peripheral Blood Biomarkers Coupled with the Apolipoprotein E4 Genotype Are Strongly Associated with Semantic and Episodic Memory Impairments in Elderly Subjects with Amnestic Mild Cognitive Impairment and Alzheimer's Disease.
    Supasitthumrong T; Tunvirachaisakul C; Aniwattanapong D; Tangwongchai S; Chuchuen P; Tawankanjanachot I; Snabboon T; Hemrungrojn S; Carvalho AF; Maes M
    J Alzheimers Dis; 2019; 71(3):797-811. PubMed ID: 31424390
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Preservation of episodic memory in semantic dementia: The importance of regions beyond the medial temporal lobes.
    Irish M; Bunk S; Tu S; Kamminga J; Hodges JR; Hornberger M; Piguet O
    Neuropsychologia; 2016 Jan; 81():50-60. PubMed ID: 26683384
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Apolipoprotein E ε4 and age effects on florbetapir positron emission tomography in healthy aging and Alzheimer disease.
    Fleisher AS; Chen K; Liu X; Ayutyanont N; Roontiva A; Thiyyagura P; Protas H; Joshi AD; Sabbagh M; Sadowsky CH; Sperling RA; Clark CM; Mintun MA; Pontecorvo MJ; Coleman RE; Doraiswamy PM; Johnson KA; Carpenter AP; Skovronsky DM; Reiman EM
    Neurobiol Aging; 2013 Jan; 34(1):1-12. PubMed ID: 22633529
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The Impact of APOE ɛ4 in Alzheimer's Disease Differs According to Age.
    Kim J; Park S; Yoo H; Jang H; Kim Y; Kim KW; Jang YK; Lee JS; Kim ST; Kim S; Lee JM; Ki CS; Na DL; Seo SW; Kim HJ
    J Alzheimers Dis; 2018; 61(4):1377-1385. PubMed ID: 29376853
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Multicentre variability of MRI-based medial temporal lobe volumetry in Alzheimer's disease.
    Teipel SJ; Ewers M; Wolf S; Jessen F; Kölsch H; Arlt S; Luckhaus C; Schönknecht P; Schmidtke K; Heuser I; Frölich L; Ende G; Pantel J; Wiltfang J; Rakebrandt F; Peters O; Born C; Kornhuber J; Hampel H
    Psychiatry Res; 2010 Jun; 182(3):244-50. PubMed ID: 20493672
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Electrocortical networks in Parkinson's disease patients with Mild Cognitive Impairment. The PaCoS study.
    Mostile G; Giuliano L; Monastero R; Luca A; Cicero CE; Donzuso G; Dibilio V; Baschi R; Terranova R; Restivo V; Sofia V; Zappia M; Nicoletti A
    Parkinsonism Relat Disord; 2019 Jul; 64():156-162. PubMed ID: 30981665
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Decreased Fronto-Parietal and Increased Default Mode Network Activation is Associated with Subtle Cognitive Deficits in Elderly Controls.
    Zanchi D; Montandon ML; Sinanaj I; Rodriguez C; Depoorter A; Herrmann FR; Borgwardt S; Giannakopoulos P; Haller S
    Neurosignals; 2017; 25(1):127-138. PubMed ID: 29268260
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Higher Peripheral TREM2 mRNA Levels Relate to Cognitive Deficits and Hippocampal Atrophy in Alzheimer's Disease and Amnestic Mild Cognitive Impairment.
    Tan YJ; Ng ASL; Vipin A; Lim JKW; Chander RJ; Ji F; Qiu Y; Ting SKS; Hameed S; Lee TS; Zeng L; Kandiah N; Zhou J
    J Alzheimers Dis; 2017; 58(2):413-423. PubMed ID: 28453482
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Topographical APOE ɛ4 Genotype Influence on Cerebral Metabolism in the Continuum of Alzheimer's Disease: Amyloid Burden Adjusted Analysis.
    Seo EH; Kim SH; Park SH; Kang SH; Choo IH;
    J Alzheimers Dis; 2016 Sep; 54(2):559-68. PubMed ID: 27567846
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.